Diabetes technology

Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge

Endocr PractPublished Randomised controlled trial

Authors' conclusion

The results of this pilot study indicate that the use of CGM leads to improved glycemic control, reduced hypoglycemia, and decreased glucose variability compared to POC glucose testing after hospital discharge.

Study context

Population
Insulin-treated patients with T2D after hospital discharge; mean age 54.3 ± 10.7 years, HbA1c 10.46 ± 2.24%, median diabetes duration 9.0 years (IQR 1.0, 42)
Participants
100 patients
Comparison
FreeStyle Libre 2 continuous glucose monitoring (CGM) vs capillary point-of-care glucose testing
Methodological detailspilot
  • Pilot

Primary result

As reported in the abstract

Glycemic control · up to 12 weeks after discharge
  • Trend toward improved glycemic control with CGM vs point-of-care (POC): increased time in range 70-180 mg/dl, reduced time above range > 180 and 250 mg/dl, decreased insulin requirements

Further findings

Healthcare utilization (ED visits, hospital admissions)

No differences in ED visits or hospitalization between groups

Safety

Trend toward decreased hypoglycemia with CGM vs POC

Original publication

Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge. Endocr Pract. Published 17 December 2024. doi:10.1016/j.eprac.2024.11.018

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.